Companies in #Neuromuscular Disease
Found 1 company operating in this sector.
Clinical-stage biotechnology company developing next-generation oligonucleotide therapies built on its Enhanced Delivery Oligonucleotide (EDO) platform of cell-penetrating peptides, aimed at severe neuromuscular and neurological diseases.